Search
Fennec Pharmaceuticals Inc
FENCAdd to Watchlist
10.620USD
+0.110+1.05%
Close 09-24 16:00（ET）
368.94MMarket Cap
LossP/E TTM
Fennec Pharmaceuticals Inc (FENC) Stock Price Target & Forecast
Analyst Rating
Based on 6 analysts giving stock ratings to Fennec Pharmaceuticals Inc in the past month.
Buy
1 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
17.667USD+68.09%
FENC Analyst Recommendation Trends
In the current month, FENC has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. FENC average Analyst price target in the last month is 17.667.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
2
2
2
2
2
5
5
5
5
5
5
5
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
6
7
7
7
7
6
FENC Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, FENC EPS is projected to reach 0.093 in FY2026Q3, following reported EPS of 0.057 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.04
-0.01
0.01
0.09
0.13
Actual
-0.15
0.01
0.06
--
--
Surprise
-538.71%
+170.23%
+480.98%
--
--
FAQs
What is Fennec Pharmaceuticals Inc's expected revenue for the next quarter?
Fennec Pharmaceuticals Inc's expected revenue is 18.81M.
What is Fennec Pharmaceuticals Inc's price target?
Analysts forecast that Fennec Pharmaceuticals Inc's price target is USD 17.67, with the highest forecast at USD 20.00 and the lowest forecast at USD 16.00.
How have Fennec Pharmaceuticals IncFENC's recent earnings per share performed?
The market expectation was USD 0.06, while Fennec Pharmaceuticals IncFENC's earnings per share (EPS) for the previous quarter was USD 0.01. EPS for the next quarter is expected at USD 0.09.
What is the analyst rating for Fennec Pharmaceuticals Inc?
Based on the ratings of Fennec Pharmaceuticals Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.